Compound Fuling Granule Suppresses Ovarian Cancer Development and Progression by disrupting mitochondrial function, galactose and fatty acid metabolism.

Abstract:

:Our previous studies have demonstrated that the compound fuling granule (CFG), a traditional Chinese medicine, suppresses ovarian cancer cell growth, migration and metastasis. However, the underlying mechanisms remain to be fully elucidated. In this study, we found that CFG could induce mitochondrial fragmentation, mitochondrial membrane potential reduction and cytochrome c release in ovarian SKOV3 cancer cells. In addition, both metabolomics and transcriptomics approaches were applied to illustrate the systemic mechanism of CFG on ovarian cancer formation and progression. To this end, we established two tumor-bearing mice models with subcutaneous injection or tail intravenous injection. Functionally, administration of CFG suppresses in situ tumor growth and distant lung metastasis. Subsequently, gas chromatography-mass spectrometry (GC-MS) was applied to determine the metabolic alterations among the plasma samples from these in vivo models. In the subcutaneous injection model, 26 distinguishable metabolites were identified and 12 metabolic pathways were reprogrammed. Meanwhile, 19 metabolites involved in 7 metabolic pathways showed significant differences in the tail intravenous injection model. Importantly, integrative metabolomics and transcriptomics analysis showed these metabolites were highly associated with galactose metabolism and fatty acid metabolism. This study suggests that CFG may suppress ovarian cancer cell proliferation and metastasis by regulating mitochondrion-related energy metabolisms.

journal_name

J Cancer

journal_title

Journal of Cancer

authors

Ruan S,Zhang Z,Tian X,Huang D,Liu W,Yang B,Shen M,Tao F

doi

10.7150/jca.25136

subject

Has Abstract

pub_date

2018-09-08 00:00:00

pages

3382-3393

issue

18

issn

1837-9664

pii

jcav09p3382

journal_volume

9

pub_type

杂志文章
  • Effects of mitochondrial translocation of telomerase on drug resistance in hepatocellular carcinoma cells.

    abstract::Hepatocellular carcinoma (HCC) cells exhibit multidrug resistance (MDR), but the underlying mechanisms remain unclear. Cancer cells that overexpress telomerase are resistant to chemotherapeutic drugs. This study aimed to determine the effects of mitochondrial translocation of telomerase on MDR in HCC cells. HepG2 cell...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.10419

    authors: Yan J,Zhou Y,Chen D,Li L,Yang X,You Y,Ling X

    更新日期:2015-01-05 00:00:00

  • Transcriptional cofactor Mask2 is required for YAP-induced cell growth and migration in bladder cancer cell.

    abstract::The highly conserved Hippo signaling pathway is an important pathway involved in tumorigenesis and development. In previous studies, YAP, the transcription coactivator of Hippo pathway, is found to be highly expressed in many clinical bladder cancer samples. To investigate the function of YAP and its cofactor Mask2 in...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.16438

    authors: Dong L,Lin F,Wu W,Huang W,Cai Z

    更新日期:2016-10-23 00:00:00

  • Combinational inhibition of EGFR and YAP reverses 5-Fu resistance in colorectal cancer.

    abstract::Yes-associated protein (YAP) is a transcriptional coactivator that promotes cell proliferation, migration, and tissue homeostasis in colorectal cancer (CRC). Here, we established 5-Fu resistant CRC cell line (SW620R) and examined the role of YAP in chemotherapy resistance. We showed that YAP promoted cell proliferatio...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.44775

    authors: Huang C,Chen Z,Yang C,Chen L,Lai C,Zhang Y,Yuan W,Jeong JH

    更新日期:2020-07-11 00:00:00

  • Simultaneous inhibition of cell-cycle, proliferation, survival, metastatic pathways and induction of apoptosis in breast cancer cells by a phytochemical super-cocktail: genes that underpin its mode of action.

    abstract::Traditional chemotherapy and radiotherapy for cancer treatment face serious challenges such as drug resistance and toxic side effects. Complementary / Alternative medicine is increasingly being practiced worldwide due to its safety beneficial therapeutic effects. We hypothesized that a super combination (SC) of known ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.7235

    authors: Ouhtit A,Gaur RL,Abdraboh M,Ireland SK,Rao PN,Raj SG,Al-Riyami H,Shanmuganathan S,Gupta I,Murthy SN,Hollenbach A,Raj MH

    更新日期:2013-11-14 00:00:00

  • Impact Of Circulating T Helper 1 And 17 Cells in the Blood on Regional Lymph Node Invasion in Colorectal Cancer.

    abstract::We hypothesised that the blood levels of immune cells would be related to the progression of colorectal cancer and regional lymph node metastasis. We investigated the association between the blood levels of immune cells and regional lymph node metastasis in colorectal cancer patients. Patients with American Joint Comm...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.18230

    authors: Lee JY,Seo EH,Oh CS,Paik JH,Hwang DY,Lee SH,Kim SH

    更新日期:2017-05-10 00:00:00

  • Tailored Selection of First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma of Bladder.

    abstract:PURPOSE:Methotrexate, vinblastine, doxorubicin plus cisplatin (MVAC) and gemcitabine plus cisplatin (GC) are both effective first-line chemotherapy. We explore the responsive variables of MVAC and GC for patients with metastatic urothelial carcinoma of bladder (mUCB). MATERIALS AND METHODS:Patients who were initially ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.15213

    authors: Hsieh MC,Huang CH,Chiang PH,Chen YY,Tang Y,Su YL

    更新日期:2016-06-27 00:00:00

  • Phosphorylated Protein Kinase C (Zeta/Lambda) Expression in Colorectal Adenocarcinoma and Its Correlation with Clinicopathologic Characteristics and Prognosis.

    abstract::Background: Protein kinase C zeta/lambda (PKCζ/λ) is a family of protein kinase enzymes that contributes to cell proliferation and regulation, which are important for cancer development. PKCζ/λ has been shown to be an important regulator of tumorigenesis in intestinal cancer. The phosphorylated form of PKCζ/λ, p-PKCζ/...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.20983

    authors: Yeo MK,Kim JY,Seong IO,Kim JM,Kim KH

    更新日期:2017-09-20 00:00:00

  • miR-365a-3p regulates ADAM10-JAK-STAT signaling to suppress the growth and metastasis of colorectal cancer cells.

    abstract::Purpose: MicroRNAs (miRNAs) are key regulators of the growth and development of a wide range of cancer types such as colorectal cancer (CRC). A number of previously studies have observed that the levels of miR-365a-3p expression are dysregulated in many cancers, but the specific role of this miRNA in CRC and its assoc...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.42731

    authors: Hong YG,Xin C,Zheng H,Huang ZP,Yang Y,Zhou JD,Gao XH,Hao L,Liu QZ,Zhang W,Hao LQ

    更新日期:2020-03-26 00:00:00

  • Advances in biophotonics detection of field carcinogenesis for colon cancer risk stratification.

    abstract::The process of neoplastic transformation of the colon involves a progression through hyperproliferative epithelium through the aberrant crypt foci→small adenoma→large adenoma→invasive cancer→metastatic disease. These are orchestrated by sequential genetic and epigenetic events which provide the underpinnings of cellul...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.5838

    authors: Backman V,Roy HK

    更新日期:2013-01-01 00:00:00

  • Integrative Oncology Physician Consultations at a Comprehensive Cancer Center: Analysis of Demographic, Clinical and Patient Reported Outcomes.

    abstract::Background: Integrative oncology (IO) is a relatively new field that seeks to bring evidence-based, non-conventional approaches into conventional oncology care in a coordinated and safe manner. Though complementary and alternative medicine (CAM) are highly utilized by cancer patients, little is known about the charact...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.17506

    authors: Lopez G,McQuade J,Cohen L,Williams JT,Spelman AR,Fellman B,Li Y,Bruera E,Lee RT

    更新日期:2017-02-10 00:00:00

  • Fibroblast growth factor receptor signaling as therapeutic targets in female reproductive system cancers.

    abstract::Ovarian cancer, cervical cancer and endometrial cancer are three relatively common malignant cancers of the female reproductive system. Despite improvements in female genital tract cancer detection and development of new therapeutic approaches, there are still poor prognoses and some do not respond to therapeutic patt...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.44727

    authors: Zhu DL,Tuo XM,Rong Y,Zhang K,Guo Y

    更新日期:2020-10-21 00:00:00

  • ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.

    abstract::We discuss the hypothesis that ZEB1-Wnt-p300 signaling integrates epithelial to mesenchymal transition (EMT) and resistance to histone deacetylase inhibitors (HDACis) in colorectal cancer (CRC) cells. The HDACi butyrate, derived from dietary fiber, has been linked to CRC prevention, and other HDACis have been proposed...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.18762

    authors: Lazarova D,Bordonaro M

    更新日期:2017-05-12 00:00:00

  • High Expression of PQBP1 and Low Expression of PCK2 are Associated with Metastasis and Recurrence of Osteosarcoma and Unfavorable Survival Outcomes of the Patients.

    abstract::Osteosarcoma (OS) is the most common primary bone malignancy, predominately affecting children and adolescents. Due to the introduction of chemotherapy, the 5-year survival rate of OS patients has dramatically improved to 60-70%. Unfortunately, OS patients with recurrence or metastatic disease have less than a 20% cha...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.28480

    authors: Zhang Y,Zhao H,Xu W,Jiang D,Huang L,Li L

    更新日期:2019-05-12 00:00:00

  • In vivo Antitumor Effect of an HPV-specific Promoter driving IL-12 Expression in an HPV 16-positive Murine Model of Cervical Cancer.

    abstract::Human papillomavirus (HPV) is a DNA virus that infects epithelial cells and has been implicated in the development of cervical cancer. Few therapeutic strategies have been designed for the treatment of cervical intraepithelial neoplasia, a precursor of cervical cancer. In these early stages, the HPV E2 protein is the ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.15536

    authors: Bermúdez-Morales VH,Fierros-Zarate G,García-Meléndrez C,Alcocer-Gonzalez JM,Morales-Ortega A,Peralta-Zaragoza O,Torres-Poveda K,Burguete-García AI,Hernández-Márquez E,Madrid-Marina V

    更新日期:2016-09-27 00:00:00

  • CDC27 Induces Metastasis and Invasion in Colorectal Cancer via the Promotion of Epithelial-To-Mesenchymal Transition.

    abstract::Distant metastasis is the primary cause of cancer-related death among patients with colorectal cancer (CRC), and the discovery of novel therapeutic targets by further exploring the molecular mechanisms of CRC metastasis is therefore urgently needed. We previously illustrated that CDC27 overexpression promoted prolifer...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.19381

    authors: Qiu L,Tan X,Lin J,Liu RY,Chen S,Geng R,Wu J,Huang W

    更新日期:2017-08-21 00:00:00

  • Interventional radiofrequency ablation: A promising therapeutic modality in the management of malignant biliary and pancreatic duct obstruction.

    abstract::Background: Malignant biliary and/or pancreatic obstruction has often encountered in the advanced stages of periampullary and cholangicarcinomas. HabibTM Radiofrequency (RF) ablation has been successfully used in the management of various cancers of liver and pancreas. Percutaneous HPB probe (EMcision Ltd, London, UK)...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.23280

    authors: Mizandari M,Kumar J,Pai M,Chikovani T,Azrumelashvili T,Reccia I,Habib N

    更新日期:2018-01-05 00:00:00

  • Efficacy of Cabazitaxel Treatment in Metastatic Castration Resistant Prostate Cancer in Second and Later Lines. An Experience from Two German Centers.

    abstract::Purpose: Several new treatment options for patients with metastatic castration resistant prostate cancer (mCRPC) have been approved within the last years - among them cabazitaxel (CAB), abiraterone acetate, enzalutamide, and radium-223. The aim of this study was to assess factors predictive for efficacy of CAB. Method...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.17644

    authors: Zschäbitz S,Vallet S,Hadaschik B,Debatin D,Fuxius S,Karcher A,Pahernik S,Spath C,Duensing S,Jäger D,Hohenfellner M,Grüllich C

    更新日期:2017-02-11 00:00:00

  • R.E.N.A.L. Nephrometry Score: A Preoperative Risk Factor Predicting the Fuhrman Grade of Clear-Cell Renal Carcinoma.

    abstract::Objective: The purpose of this study was to evaluate the efficacy and feasibility of the R.E.N.A.L. Nephrometry Score to postoperatively predict high-grade clear-cell renal carcinoma (ccRCC). Methods: The study included 288 patients diagnosed with ccRCC who had complete CT/CTA data and R.E.N.A.L. Nephrometry Scores an...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.21189

    authors: Chen SH,Wu YP,Li XD,Lin T,Guo QY,Chen YH,Huang JB,Wei Y,Xue XY,Zheng QS,Xu N

    更新日期:2017-10-17 00:00:00

  • Perspectives of breast cancer thermotherapies.

    abstract::In this article, the use of different types of thermotherapies to treat breast cancer is reviewed. While hyperthermia is most commonly used as an adjuvant in combination with radiotherapy, chemotherapy, targeted therapy or cryotherapy to enhance the therapeutic effect of these therapies, thermoablation is usually carr...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.8693

    authors: Alphandéry E

    更新日期:2014-05-29 00:00:00

  • Lung cancer in young adults aged 35 years or younger: A full-scale analysis and review.

    abstract::Objectives: Lung cancer in young adults is a distinct disease with particular socioeconomic implications. This study aimed to clarify the clinicopathological characteristics, best interventions, and outcomes of this distinctive entity. Methods: A retrospective review of patients with lung cancer was performed in our i...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.27490

    authors: Liu B,Quan X,Xu C,Lv J,Li C,Dong L,Liu M

    更新日期:2019-06-09 00:00:00

  • Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma.

    abstract::Purpose: Systemic therapy has often been used for patients with advanced hepatocellular carcinoma (HCC). However, due to drug resistance, the use of cytotoxic chemotherapy in the treatment of patients with advanced HCC has typically demonstrated low response rates. Secretory clusterin (sCLU) is expressed in aggressive...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.23849

    authors: Wang X,Zou F,Zhong J,Yue L,Wang F,Wei H,Yang G,Jin T,Dong X,Li J,Xiu P

    更新日期:2018-04-06 00:00:00

  • Association between SNPs in Long Non-coding RNAs and the Risk of Female Breast Cancer in a Chinese Population.

    abstract::Long non-coding RNAs (LncRNAs) have been reported to be involved in tumorigenesis and tumor progression. Single nucleotide polymorphisms (SNPs) in the lncRNAs also play a vital role in carcinogenesis. The aim of this study was to assess the relationships between the four selected tagSNPs (rs944289, rs3787016, rs145631...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.18055

    authors: Xu T,Hu XX,Liu XX,Wang HJ,Lin K,Pan YQ,Sun HL,Peng HX,Chen XX,Wang SK,He BS

    更新日期:2017-04-09 00:00:00

  • Dysregulation of MiR-519d Affects Oral Squamous Cell Carcinoma Invasion and Metastasis by Targeting MMP3.

    abstract::MicroRNA-519d (miR-519d) has been reported to play important roles in tumor development and progression in multiple cancers, either as tumor suppressor or tumor promotor. However, the expression level, biological function and molecular mechanisms of miR-519d in oral squamous cell carcinoma (OSCC) remain unclear. There...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.31825

    authors: Jin Y,Li Y,Wang X,Yang Y

    更新日期:2019-06-02 00:00:00

  • Prognostic and Clinicopathological Significance of lncRNA MVIH in Cancer Patients.

    abstract::Objectives: LncRNA associated with microvascular invasion in hepatocellular carcinoma (lncRNA MVIH) is a newly discovered long non-coding RNA that aberrantly up-regulates and holds prognostic value in various tumors. The aim of the review and meta-analysis is to assess its prognostic potential and functions in maligna...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.28541

    authors: Zhang Y,Lin S,Yang X,Zhang X

    更新日期:2019-02-26 00:00:00

  • The Role of Galectins in Tumor Progression, Treatment and Prognosis of Gynecological Cancers.

    abstract::Galectins are the member of soluble proteins that bind with β-galactoside containing glycans. These proteins have been considered to be associated in various important events such as different types of cancers. It has been found that galectins could contribute to neoplastic transformation or regulate cell growth, cell...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.23628

    authors: Chetry M,Thapa S,Hu X,Song Y,Zhang J,Zhu H,Zhu X

    更新日期:2018-11-25 00:00:00

  • Latest Overview of the Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: The Past, the Present and the Future.

    abstract::Endocrine resistance in hormone receptor positive breast cancer patients urges us to develop novel approaches such as inhibitors of the cyclin-dependent kinases (CDK) 4/6 to reverse its resistance. Nowadays, three selective CDK4/6 inhibitors (Palbociclib, Ribociclib and Abemaciclib) are approved by Federal Drug Admini...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.33079

    authors: Chen X,Xu D,Li X,Zhang J,Xu W,Hou J,Zhang W,Tang J

    更新日期:2019-10-21 00:00:00

  • Overexpression of Citron Rho-Interacting Serine/Threonine Kinase Associated with Poor Outcome in Bladder Cancer.

    abstract::Objective: Citron Rho-Interacting Serine/Threonine Kinase (CIT) was originally identified as a binding partner of active forms of the small GTPases Rho and Rac. This kinase participated in the regulation of cytokinesis and loss of CIT was associated with chromosomal instability. Here, we assume that CIT might be a pot...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.43435

    authors: Shou J,Yu C,Zhang D,Zhang Q

    更新日期:2020-04-14 00:00:00

  • The Long Noncoding RNA MALAT-1 is A Novel Biomarker in Various Cancers: A Meta-analysis Based on the GEO Database and Literature.

    abstract:BACKGROUND:MALAT-1 is significantly overexpressed in various cancers, suggesting that it might be a potential biomarker of cancer. METHODS:A meta-analysis was performed using microarray data obtained via the Affymetrix Human Genome U133 Plus 2.0 platform found in the Gene Expression Omnibus (GEO) database and data obt...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.14663

    authors: Wang Y,Xue D,Li Y,Pan X,Zhang X,Kuang B,Zhou M,Li X,Xiong W,Li G,Zeng Z,Yang T

    更新日期:2016-05-20 00:00:00

  • Glioblastoma Treatment Modalities besides Surgery.

    abstract::Glioblastoma multiforme (GBM) is commonly known as the most aggressive primary CNS tumor in adults. The mean survival of it is 14 to 15 months, following the standard therapy from surgery, chemotherapy, to radiotherapy. Efforts in recent decades have brought many novel therapies to light, however, with limitations. In...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.32475

    authors: Zhang H,Wang R,Yu Y,Liu J,Luo T,Fan F

    更新日期:2019-08-27 00:00:00

  • Inhibition of Tumor Lymphangiogenesis is an Important Part that EGFR-TKIs Play in the Treatment of NSCLC.

    abstract::Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used to treat non-small cell lung cancer (NSCLC) because they inhibit tumour growth and metastasis. However, the underlying mechanisms are not fully understood. Here, we investigate whether anti-lymphangiogenesis mechanisms cont...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.35448

    authors: Zhang Y,Yang X,Liu H,Cai M,Shentu Y

    更新日期:2020-01-01 00:00:00